Pasar al contenido principal

FUNCION Y ESPECIFICIDAD DE LAS VARIANTES DE LA HISTONA H1 HUMANA EN LA ORGANIZACION Y CONTROL DEL GENOMA

PID2023-146239OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

The Impact of Transposable Elements on Immune Pathways

  • Salinas Pena, Mónica
  • Homs-Aguadé, Pau
  • Jordan, Albert
This chapter explores the intricate interplay between transposable elements (TEs) and the immune system, emphasizing their dual role as regulators and activators within immune pathways. TEs have been co-opted to play critical roles in immune cell function and the regulation of immune-related genes, serving as cis-regulatory elements that shape transcriptional networks. Beyond these regulatory functions, the activation of endogenous TEs can profoundly impact immune responses, particularly through their ability to initiate immune signaling cascades. This process, termed viral mimicry, occurs when endogenous TE-derived nucleic acids are expressed and detected in the cytosol, triggering antiviral interferon responses. Such TE-driven immune modulation represents a promising approach for enhancing anti-cancer immunity. Furthermore, TE-derived transcripts demonstrate immunogenic potential and act as a reservoir for neoantigen generation. Overall, this chapter provides a comprehensive overview of the multifaceted roles of TEs in shaping immune responses, with a focus on their translational potential in cancer therapy., This work was funded by the Spanish Ministry of Science, Innovation and Universities and FEDER, EU (grant number PID2023-146239OB-I00/AEI/10.13039/501100011033). We also acknowledge the Generalitat de Catalunya Suport Grups de Recerca AGAUR (grant number 2017-SGR-597)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

H1.3 depletion in AML cells prompts H1.2 redistribution, chromatin remodeling and cell cycle defects

  • Tellez-Quijorna, Clara
  • N’Guyen, Lia
  • Serna-Pujol, Núria
  • Rodies, Maeva
  • Homs-Aguadé, Pau
  • Vernerey, Julien
  • Jordan, Albert
  • Duprez, Estelle
Linker histone H1 variants play critical, yet distinct, roles in chromatin organization and gene regulation. However, their specificity in cancer cells is not well understood. Our previous studies have shown that acute myeloid leukemia (AML) patients who were H3K27me3HIST1-positive exhibited lower H1.3 expression and a favorable outcome. These results imply that the H1.3 linker histone may play an unknown role in AML progression. In this study, we investigated the function of the H1.3 variant in AML cells. Through chromatin mapping and transcriptomic analyses, we revealed that H1.3 was enriched in regions with a high GC content and colocalized with the repressive mark H3K27me3. This supports its role in chromatin compaction and transcriptional repression. Knockout of H1.3 induced specific changes in gene expression profiles and chromatin dynamics, characterized by a changed in H1.2 localization, which was redistributed from its usual chromatin regions to H1.3 regions. Consequently, we observed chromatin alterations associated with changes in gene programs affecting interferon-related signaling and cell cycle regulation. Overall, our study revealed a mechanistic connection between H1.3 variant imbalance, immune response activation, and cell cycle regulation, with implications for our understanding of epigenetic regulation in AML cells., This work was supported by the Ligue Nationale Contre le Cancer ; the Institut National de la Santé et de la Recherche Médicale (INSERM) ; the Centre National de la Recherche Scientifique (CNRS); the Canceropôle Provence Alpes Côte d’Azur, the Institute for Cancer and Immunology (Aix-Marseille University), by a grant from l’Institut National du Cancer (PRT-K16-071 to E.D.), which also funded LNG ; a European Union’s Horizon 2020 Research and Innovation Program (Marie Skłodowska-Curie grant # 813091 ARCH, age-related changes in hematopoiesis (that funded CT), by the Spanish Ministry of Science, Innovation and Universities and FEDER, EU (grant number PID2023-146239OB-I00/AEI/https://doi.org/10.13039/501100011033). We also acknowledge the Generalitat de Catalunya Suport Grups de Recerca AGAUR (grant number 2017-SGR-597)., Peer reviewed